<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In rats: No abnormalities in the general behavior or death were observed on the 1st day in the group of the female rats that were given the MMEO at the dose of 2000 mg/kg of body weight. Abnormalities occurred in the male rats that had taken the MMEO in the form of symptoms such as hypoactivity and drowsiness. In the acute test, there were no changes in body weight and food consumption in the male and female rats compared to the controls. There was no mortality observed at the tested dose, and nor was there any weight loss in the rats. Moreover, there was no mortality in both rats and mice; therefore, the oral LD
 <sub class="sub">50</sub> value of the MMEO was greater than 2000 mg/kg. 
</p>
